Pharmaxis

Developer of drugs for inflammatory and fibrotic diseases

placeSydney, New South Wales, Australia calendar_todayFounded 1998 groups93 employees language pharmaxis.com.au

Registered entities

Social engagement

Social engagement: 4K social following, 7 posts in the last 12 months — below the industry typical range.

Investor mix

11 investors on record; 2 have since exited.

Investor typeCountShare
Venture capital327%
Private equity545%
Other / undisclosed327%

Recent activity

17 Jun 2026
Event
ECM Pharmacology Conference (ECM2026)
1 Jun 2026
Event
SNT-4728 webinar presentation
28 May 2026
Event
investor webinar on Phase 2 trial of SNT-4728
Coming soon